Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

ADXN

Addex Therapeutics (ADXN)

Addex Therapeutics Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ADXN
FechaHoraFuenteTítuloSímboloCompañía
08/05/202400:00GlobeNewswire Inc.Addex to Present at Bio€quity Europe 2024NASDAQ:ADXNAddex Therapeutics Ltd
29/04/202400:00GlobeNewswire Inc.Addex Provides Update on ADX71149 Phase 2 Epilepsy StudyNASDAQ:ADXNAddex Therapeutics Ltd
19/04/202400:00GlobeNewswire Inc.Addex to Present at the Swiss Biotech Day 2024NASDAQ:ADXNAddex Therapeutics Ltd
18/04/202400:00GlobeNewswire Inc.Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
11/04/202400:00GlobeNewswire Inc.Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024NASDAQ:ADXNAddex Therapeutics Ltd
03/04/202400:00GlobeNewswire Inc.Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological DisordersNASDAQ:ADXNAddex Therapeutics Ltd
14/03/202401:00GlobeNewswire Inc.Addex to Present at the Bio-Europe Spring 2024 ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
31/01/202400:00GlobeNewswire Inc.Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.NASDAQ:ADXNAddex Therapeutics Ltd
30/01/202416:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ADXNAddex Therapeutics Ltd
30/01/202415:58Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
09/01/202400:00GlobeNewswire Inc.Addex to Present at the Swiss Equities Baader ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
05/01/202400:30GlobeNewswire Inc.Addex to Present at Biotech Showcase™ 2024NASDAQ:ADXNAddex Therapeutics Ltd
21/12/202305:00Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:ADXNAddex Therapeutics Ltd
20/12/202300:00GlobeNewswire Inc.Addex Shareholders Approve All Resolutions at Extraordinary General MeetingNASDAQ:ADXNAddex Therapeutics Ltd
14/12/202300:00GlobeNewswire Inc.Addex Creates Treasury SharesNASDAQ:ADXNAddex Therapeutics Ltd
08/12/202313:11Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ADXNAddex Therapeutics Ltd
30/11/202315:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ADXNAddex Therapeutics Ltd
29/11/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ADXNAddex Therapeutics Ltd
29/11/202305:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ADXNAddex Therapeutics Ltd
29/11/202300:00GlobeNewswire Inc.Addex Reports Q3 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
28/11/202300:00GlobeNewswire Inc.Addex Convenes Extraordinary General MeetingNASDAQ:ADXNAddex Therapeutics Ltd
23/11/202300:00GlobeNewswire Inc.Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on November 29, 2023NASDAQ:ADXNAddex Therapeutics Ltd
14/11/202300:00GlobeNewswire Inc.Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of PatientsNASDAQ:ADXNAddex Therapeutics Ltd
08/11/202300:00GlobeNewswire Inc.Addex Regains Nasdaq Listing ComplianceNASDAQ:ADXNAddex Therapeutics Ltd
02/11/202301:00GlobeNewswire Inc.Addex Announces Participation in the Bio-Europe 2023 ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
20/10/202300:00GlobeNewswire Inc.Addex Completes ADS Ratio ChangeNASDAQ:ADXNAddex Therapeutics Ltd
06/10/202315:00GlobeNewswire Inc.Addex Announces Plan to Implement ADS Ratio ChangeNASDAQ:ADXNAddex Therapeutics Ltd
20/09/202300:00GlobeNewswire Inc.Addex mGlu2 NAM Cognition Program Receives €4 Million GrantNASDAQ:ADXNAddex Therapeutics Ltd
06/09/202300:00GlobeNewswire Inc.Addex Announces Participation in the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
05/09/202300:00GlobeNewswire Inc.Addex ADX71149 Phase 2 Epilepsy Study Expected to Readout Data in Q2 2024NASDAQ:ADXNAddex Therapeutics Ltd
 Showing the most relevant articles for your search:NASDAQ:ADXN